Stereotactic irradiation using a linear accelerator for brain metastasis from renal cell carcinoma
- 38 Downloads
The role of stereotactic irradiation using a linear accelerator for brain metastasis from renal cell carcinoma was investigated.
Fifteen brain metastases in 11 patients with a history of renal cell carcinoma were treated using convergent narrow x-ray beams from a linear accelerator and rigid fixation of the head with a stereotactic frame. Twelve metastatic tumors in8 patients were irradiated with 25 Gy at the center in a single fraction, and single tumors in 3 patients received the following doses: 25 Gy in 5 fractions, 28 Gy in 3 fractions, or 35 Gy in 4 fractions
The actuarial local control rate at 12 months was 90.6%. Twelve (92%) of 13 lesions that produced neurologic symptoms before stereotactic irradiation showed an improvement of symptoms. No complication related to the irradiation was observed. The median survival time was 6 months.
Stereotactic irradiation is more effective in achieving local control than is conventional radiotherapy, and achieves improvement in symptoms and survival rates similar to those of surgical resection of the brain metastasis from renal cell carcinoma. Urologists and oncologists should be aware of the usefulness of stereotactic radiation in the management of patients with renal cell carcinoma.
Key wordsstereotactic radiosurgery radiotherapy brain metastasis renal cell carcinoma
Unable to display preview. Download preview PDF.
- 5.Auchter RM, Lamond JP, Alexander III E, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Levin AB, Noyes WR, Schults CJ, Loeffler JS, Mehta MP. A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Bio Phys 1996;35:27–35.CrossRefGoogle Scholar
- 7.Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR, Sneed PK, Larson DA. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Bio Phys 1994;28:797–802.Google Scholar
- 8.Shirato H, isu T, Matsumura S, Terae S, Nanbu T, Suzuki K, Nishioka T, Shimizu T. Daily intermittent multiportal therapy followed by stereotactic boost (DIMT-SB) for treatment of small intracranial lesions-technical aspects and preliminary results. J Jpn Soc Ther Radiol Oncol 1992;4:149–162.Google Scholar
- 10.Fuller BG, Kaplan ID, Adler J, Cox RS, Bagshaw MA. Stereotaxic radiosurgery for brain metastasis: the importance of adjuvant whole brain irradiation. Int J Radiat Oncol Bio Phys 1992;23:413–418.Google Scholar
- 11.Seitz W, Karcher KH, Binder W. Radiotherapy of metastatic renal cell carcinoma. Sem Surg Oncol 1988;4:100–102.Google Scholar
- 12.Loeffler JS, Alexander III E. Radiosurgery for the treatment of intracranial metastasis. In: Loeffler JS, Alexander III E, Lunsford LD, eds Stereotactic radiosurgery. New York; McGraw-Hill, 1993:197–206.Google Scholar